Ian Dunn to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Ian Dunn has written about Neoplasm Recurrence, Local.
Connection Strength
2.205
-
Medical management of meningioma in the era of precision medicine. Neurosurg Focus. 2018 04; 44(4):E3.
Score: 0.492
-
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression. Pituitary. 2021 Jun; 24(3):359-373.
Score: 0.150
-
Immunophenotype of Vestibular Schwannomas. Otol Neurotol. 2020 12; 41(10):e1290-e1296.
Score: 0.148
-
Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis. Pituitary. 2021 Jun; 24(3):429-437.
Score: 0.148
-
Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection. Neurosurgery. 2020 10 15; 87(5):900-909.
Score: 0.147
-
Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2020 Jan; 146(1):111-120.
Score: 0.138
-
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. J Clin Oncol. 2019 03 20; 37(9):741-750.
Score: 0.130
-
Genomic characterization of recurrent high-grade astroblastoma. Cancer Genet. 2016 Jul-Aug; 209(7-8):321-30.
Score: 0.109
-
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst. 2016 Feb; 108(2).
Score: 0.104
-
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma. Neuro Oncol. 2016 Feb; 18(2):269-74.
Score: 0.103
-
Multicentric Low-Grade Gliomas. World Neurosurg. 2015 Oct; 84(4):1045-50.
Score: 0.101
-
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014 Nov; 16(11):1547-53.
Score: 0.094
-
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. J Clin Oncol. 2023 01 20; 41(3):618-628.
Score: 0.042
-
A molecularly integrated grade for meningioma. Neuro Oncol. 2022 05 04; 24(5):796-808.
Score: 0.041
-
Biology and Treatment of Meningiomas: A Reappraisal. Hematol Oncol Clin North Am. 2022 02; 36(1):133-146.
Score: 0.040
-
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022 01 05; 24(1):101-113.
Score: 0.040
-
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med. 2019 01; 8(1):13-20.
Score: 0.032
-
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol. 2017 Dec; 135(3):581-591.
Score: 0.030
-
High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathol. 2016 Jul; 33(3):222-7.
Score: 0.027
-
Extracranial growth of glioblastoma multiforme. J Clin Neurosci. 2015 Sep; 22(9):1521-3.
Score: 0.025
-
ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genet. 2015 Jun; 208(6):345-50.
Score: 0.025
-
Patterns in neurosurgical adverse events: intracranial neoplasm surgery. Neurosurg Focus. 2012 Nov; 33(5):E16.
Score: 0.021
-
Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer. Br J Cancer. 2002 Sep 09; 87(6):654-8.
Score: 0.010
-
Assessment of alterations in gene expression in recurrent malignant glioma after radiotherapy using complementary deoxyribonucleic acid microarrays. Neurosurgery. 2001 Jan; 48(1):195-201; discussion 201-2.
Score: 0.009